Northstar Insights by Catalyst 3 https://www.thecatalyst3.com/insights/ One article a week from the oncology literature, with a response from Catalyst 3 for oncology practice leaders. en-us Sun, 08 Nov 2026 12:00:00 GMT Home Self-Administration of SC Trastuzumab and the Infusion Chair https://www.thecatalyst3.com/insights/home-subcutaneous-trastuzumab-chair-time https://www.thecatalyst3.com/insights/home-subcutaneous-trastuzumab-chair-time Sun, 08 Nov 2026 12:00:00 GMT A Dutch microcosting study in JCO Oncology Practice found that patients giving their own subcutaneous trastuzumab at home used far less nurse and chair time. Here's what it measured, what it didn't, and what U.S. oncology practices should weigh before drawing conclusions.